Redesigning Health in Europe for 2020

Redesigning Health in Europe for 2020
eHealth Task Force Report
In 2020 the health and health care of our citizens could look quite different. We find ourselves today on the threshold of a new era with many opportunities for radical improvements in the way we manage and receive health care. In order to ensure the sustainability of our health care systems, there is a need to tackle considerable challenges. This report focuses on how to achieve a vision of affordable, less intrusive and more personalised care. Ultimately, increasing the quality of life as well as lowering mortality. Such a vision depends on the application of ICT and the use of data. The Task Force behind this report was convened to explore the potential of ICT in health innovation in the EU and make recommendations on what could be done now to ensure that Europe reaps the full benefits of eHealth in 2020.

Today, healthcare costs in Europe are climbing. Healthcare is a constantly growing component of public finances, rising to 9 % of GDP and representing between 6% and 15% of government spending in most EU countries. These costs are driven by demographic changes, a dramatic increase in chronic conditions linked to unhealthy lifestyles, expensive new technologies and products, the need for more specialised skills and the demand for high level care.

Download Redesigning Health in Europe for 2020 (.pdf, 9.293 KB).

Download from eHealthNews.eu Portal's mirror: Redesigning Health in Europe for 2020 (.pdf, 9.293 KB).

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...